MedPath

Uthealth Houston

Uthealth Houston logo
🇺🇸United States
Ownership
Private
Established
1967-01-01
Employees
11
Market Cap
-
Website
https://www.cizikeyedoctors.org

Docetaxel Followed by Provenge in Metastatic Prostate Cancer

Phase 2
Withdrawn
Conditions
Prostate Cancer
Interventions
Biological: Sipuleucel-T
First Posted Date
2016-06-08
Last Posted Date
2017-10-30
Lead Sponsor
The University of Texas Health Science Center, Houston
Registration Number
NCT02793765
Locations
🇺🇸

UTHealth Memorial Hermann Cancer Center, Houston, Texas, United States

Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer

Phase 2
Withdrawn
Conditions
Prostate Cancer
Interventions
Biological: Sipuleucel-T
First Posted Date
2016-06-08
Last Posted Date
2017-10-30
Lead Sponsor
The University of Texas Health Science Center, Houston
Registration Number
NCT02793219
Locations
🇺🇸

UTHealth Memorial Hermann Cancer Center, Houston, Texas, United States

Prospective Tumor Response Evaluation

Terminated
Conditions
Hepatocellular Cancer
Metastatic Liver Cancer
Interventions
Procedure: Y-90
Procedure: IRE
Procedure: MWA
Procedure: TACE
First Posted Date
2016-06-01
Last Posted Date
2018-10-18
Lead Sponsor
The University of Texas Health Science Center, Houston
Target Recruit Count
10
Registration Number
NCT02787954
Locations
🇺🇸

University of Texas Health Science Center Houston, Houston, Texas, United States

Role of the Orexin Receptor System in Stress, Sleep and Cocaine Use

Phase 2
Completed
Conditions
Cocaine Use Disorder
Anxiety
Interventions
Drug: Placebo (for suvorexant)
First Posted Date
2016-05-27
Last Posted Date
2019-12-11
Lead Sponsor
The University of Texas Health Science Center, Houston
Target Recruit Count
20
Registration Number
NCT02785406
Locations
🇺🇸

The University of Texas Health Science Center at Houston, Houston, Texas, United States

Efficacy of Sildenafil in Preterm Preeclampsia

Phase 2
Withdrawn
Conditions
Preterm Preeclampsia
Interventions
Drug: Placebo
First Posted Date
2016-05-25
Last Posted Date
2018-03-27
Lead Sponsor
The University of Texas Health Science Center, Houston
Registration Number
NCT02782559

PPARγ Agonist Treatment for Cocaine Dependence

Phase 1
Completed
Conditions
Cocaine Use Disorder
Alcohol Use Disorder
Interventions
Drug: Placebo
Behavioral: Therapy
Behavioral: Contingency Management
First Posted Date
2016-05-17
Last Posted Date
2018-04-26
Lead Sponsor
The University of Texas Health Science Center, Houston
Target Recruit Count
30
Registration Number
NCT02774343
Locations
🇺🇸

The University of Texas Health Science Center at Houston, Houston, Texas, United States

Dexamethasone or Clonidine as Adjuncts to Ropivacaine for Caudal Analgesia on Analgesia Duration in Children

Phase 4
Conditions
Postoperative Pain
Interventions
First Posted Date
2016-05-16
Last Posted Date
2016-05-16
Lead Sponsor
The University of Texas Health Science Center, Houston
Target Recruit Count
155
Registration Number
NCT02773602
Locations
🇺🇸

Memorial Hermann Hospital, Houston, Texas, United States

The National Center for Testing Treatments in Chronic Spinal Cord and Traumatic Brain Injury

Conditions
Spinal Cord Injury
Traumatic Brain Injury
Interventions
Other: Data and sample repository
First Posted Date
2016-05-11
Last Posted Date
2024-08-26
Lead Sponsor
The University of Texas Health Science Center, Houston
Target Recruit Count
5000
Registration Number
NCT02769416
Locations
🇺🇸

The University of Texas Health Science Center at Houston, Houston, Texas, United States

Investigation of Hypermobility, Biomarkers, and Pain Generators in Chronic Pain Patients

Terminated
Conditions
Spinal Stenosis
Nerve Root Disorder
Radiculopathy, Cervical
Benign Hypermobility Syndrome
Low Back Pain, Mechanical
Interventions
Other: Beighton score for hypermobility
First Posted Date
2016-05-04
Last Posted Date
2020-11-12
Lead Sponsor
The University of Texas Health Science Center, Houston
Target Recruit Count
31
Registration Number
NCT02761928
Locations
🇺🇸

University of Texas Health Science Center at Houston, Houston, Texas, United States

The Comparative Effectiveness of Liberal Versus Restricted Maternal Administration of Oxygen During Labor

Not Applicable
Completed
Conditions
Maternal Oxygen Use in Labor
Interventions
Drug: Liberal use of maternal oxygen
Drug: Indicated use of maternal oxygen
First Posted Date
2016-04-27
Last Posted Date
2020-10-12
Lead Sponsor
The University of Texas Health Science Center, Houston
Target Recruit Count
844
Registration Number
NCT02752490
Locations
🇺🇸

Children's Memorial Hermann Hospital, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath